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Resident macrophages densely populate the normal arterial wall, yet their origins and the 
mechanisms that sustain them are poorly understood. Using gene expression profiling we 
show here that arterial macrophages constitute a distinct population among macrophages. 
Using multiple fate mapping approaches, we show that arterial macrophages arise 
embryonically from CX3CR1+ precursors and postnatally from bone marrow-derived 
monocytes that colonize the tissue immediately after birth. In adulthood, proliferation 
rather than monocyte recruitment sustains arterial macrophages in the steady-state and 
after severe depletion following sepsis. After infection, arterial macrophages return to 
functional homeostasis rapidly. Finally, survival of resident arterial macrophages depends 
on a CX3CR1-CX3CL1 axis within the vascular niche.
  
Most tissues of the body harbor resident macrophages. Yet, macrophages are phenotypically and 
functionally heterogeneous, a reflection of the diversity of tissue environments in which they 
reside. In addition to maintaining tissue homeostasis and responding to invading pathogens, 
macrophages contribute to numerous pathological processes, making them an attractive potential 
target for therapeutic intervention. To do so, however, will require a detailed understanding of 
macrophage origins, the mechanisms that maintain them, and their functional attributes in 
different tissues and disease contexts.  
 
Macrophage ontology has long engendered controversy1,2. Nevertheless, the concept that tissue 
macrophages develop exclusively from circulating bone marrow-derived monocytes has 
prevailed for nearly a half century3. Accumulated evidence, however, including recent studies 
using sophisticated fate-mapping approaches, have determined that some tissue macrophages and 
their precursors are established embryonically in the yolk sac (YS) and fetal liver before the 
onset of definitive hematopoiesis4-11. Regardless of their origin, tissue macrophages can maintain 
themselves in adulthood by self-renewal independent of blood monocytes12,13. 
 
Gene-expression profiling of macrophage populations from several tissues has established that 
only a small number of transcripts are expressed by all macrophages14, indicating the importance 
of the context provided by the tissue when studying macrophage function in homeostasis and 
disease. The normal arterial wall contains many tissue resident macrophages that contribute 
crucially to immunity, tissue homeostasis and wound healing following injury15. However, the 
regulatory networks, ancestry and mechanisms that maintain arterial macrophages remain 
unknown. 
 
Using gene expression analysis, we show that arterial macrophages constitute a distinct 
population among tissue macrophages. Multiple fate mapping approaches demonstrated that 
arterial macrophages arise embryonically from CX3CR1+ precursors and postnatally from bone 
marrow-derived monocytes that colonize the tissue during a brief period immediately after birth. 
In adulthood, arterial macrophages were maintained by CX3CR1-CX3CL1 interactions and local 
proliferation without significant further contribution from blood monocytes. Self-renewal also 
  
sustained arterial macrophages after severe depletion during polymicrobial sepsis, rapidly 
restoring them to functional homeostasis.  
 
Results 
Phenotype and gene expression profiling of arterial macrophages. 
Flow cytometry-based analysis of single cell suspensions from healthy aortae of 6-8 week old 
mice revealed that 38 ± 4% of all CD45+ leukocytes were macrophages, identified as 
F4/80+CD11b+ cells (Fig. 1a). Other myeloid cell populations observed included 
F4/80loCD11c+MHCII+ dendritic cells (Fig. 1a) and F4/80loCD64+Ly6Chi/lo monocytes (Fig. 1a). 
Principal component analysis revealed a distinct transcriptome in arterial macrophages, which 
clustered near other macrophage populations including microglia, alveolar macrophages, and 
splenic red pulp macrophages, as characterized by the Immunological Genome Consortium (Fig. 
1b, Supplementary Fig. 1a)14. Stringent comparison of gene-expression profiles among arterial, 
brain, alveolar and splenic red pulp macrophages revealed 212 transcripts that were at least 
fivefold higher or lower in arterial macrophages relative to expression in all three of the other 
macrophage populations (Fig. 1c,d and Supplementary Fig. 1b,c). To gain insight into 
biological processes, transcripts encoding molecules with annotated functions were grouped 
according to Gene Ontology (GO) terms. Transcripts that were more abundant in arterial 
macrophages were enriched for molecular terms including translation and regulation of cell 
proliferation. The less abundant transcripts yielded GO enrichment of terms including 
homeostatic process, cell proliferation and macromolecular complex subunit organization 
(Supplementary Table 1). Flow cytometry analysis of specific cell surface markers confirmed 
arterial macrophages share features with macrophage populations from other organs as well as 
express a unique signature. In addition to the core signature macrophage markers CD64, which 
encodes the immunoglobulin Fc receptor and the tyrosine kinase receptor MerTK16, arterial 
macrophages expressed Lyve-1, CD68, MHCII, CD86, the class A scavenger receptor Msr1, 
TLR4 and Tim-4 (Fig. 1a,e). 
 
Zbtb46, encoding a member of the transcription factor family BTB-ZF, is selectively expressed 
in classical dendritic cells (cDC)17,18. Analysis of Zbtb46+/gfp mice, in which a GFP reporter 
cassette replaces exon 2 of the Zbtb46 BTB domain, revealed high expression of Zbtb46 in 
  
CD11c+MHCII+CD11b− cDC of the aorta, liver, lung and brain (Fig. 1f). GFP was undetected in 
alveolar macrophages and Kupffer cells, but was expressed in microglia and aortic macrophages, 
albeit lower than in cDC (Fig. 1f). These data extend recent observations that resident 
macrophages in some tissues express Zbtb4619, and showed that the amount of Zbtb46 
expression, as inferred from the GFP reporter, discriminated between macrophages and cDC in 
the arterial wall. cDC were also distinguished from macrophages by expression of the integrin 
alpha X (CD11c) (Fig. 1g). 
 
Intravenous administration of clodronate liposomes depleted blood monocytes, but not aortic 
macrophages (Supplementary Fig. 1d), indicating that arterial macrophages reside within the 
vessel wall. To examine the spatial distribution of arterial macrophages in more detail, we 
dissected the inner intimal and medial layers from the outer adventitia20 and assessed the number 
of macrophages by flow cytometry. The adventitia contained significantly more CD45+ 
leukocytes than the intimal or medial layers of the vessel wall (Supplementary Fig. 1e). 
Consistent with this observation, macrophage percentage among CD45+ cells (Fig. 1h), and 
number (Fig. 1i) were markedly higher in the adventitia compared to the intima and media 
layers. We next used confocal microscopy to visualize CD68+ cells in the intima, media and 
adventitia compartments of the aorta. On average, 29 ± 1% of the tissue area within the 
adventitia stained positive for CD68 (Fig. 1j). In contrast, only 2.0 ± 0.2% of tissue area in the 
intima and media stained positive for CD68 (Fig. 1j). Analysis at various locations in the aorta 
demonstrated comparable differences in macrophage content within the adventitia and intima 
and media (Fig. 1j). Consistent with previous studies, CD11c+ DC were most abundant in the 
intima of the aortic valves and arch (Supplementary Fig. 1f and21,22). We also detected 
macrophages in the carotid as well as femoral arteries (Supplementary Fig. 1g), indicating that 
resident macrophages occupy multiple arterial sites. 
 
Arterial macrophages have embryonic and postnatal origins. 
In many tissues, resident macrophages arise from embryonic precursors before birth5-7,2310,11. 
Similarly, arterial macrophages were observed in the aorta of mice at E16.5 (Fig. 2a). Flow 
cytometry revealed 2 phenotypically distinct F4/80-expressing cell populations in the developing 
embryo; F4/80hiCD11blo cells that resembled YS-derived macrophages6, and F4/80intCD11bhi 
  
cells that appeared similar in phenotype to c-Myb-dependent fetal liver monocytes7,24. At birth, 
arterial macrophages were predominately F4/80hiCD11blo, although this phenotype was transient 
and by 2 weeks of age the F4/80+ cells in the aortic wall were mainly F4/80intCD11bhi (Fig. 2a). 
The proportion of arterial macrophages among CD45+ cells increased with age (Fig. 2b) and was 
associated with progressively increased expression of MHCII (Fig. 2c), indicating a postnatal 
period of maturation. 
 
The extra-embryonic YS is the main hematopoietic site in mice before 
E10.04,25.  hematopoiesis supplies erythroid as well as myeloid precursors to the embryo 
following the onset of blood circulation at <E9.0. Because arteries contained macrophages before 
birth, we investigated whether YS progenitors contributed to the arterial macrophage pool using 
pulse labeling of CX3CR1+ progenitor cells in the YS12. Female CX3CR1CreER mice26, which upon 
exposure to tamoxifen (TAM) express Cre recombinase under the control of the CX3CR1 
promoter, were crossed to male Rosa26Tomato reporter mice and pregnant animals were injected 
with a single intraperitoneal dose of TAM at E8.5. This approach induces the preferential and 
irreversible expression of the Tdtomato reporter in YS-derived CX3CR1+ cells and their progeny. 
68 ± 8% of brain microglia in CX3CR1creER R26Tomato animals were Tdtom+ at E16.5, indicating 
robust labeling efficiency of YS progenitors and their progeny (data not shown). Consistent with 
the hypothesis that YS progenitors give rise to arterial macrophages during embryogenesis, 
>40% of F4/80hiCD11blo cells in aortae of mice at E16.5 and the day of birth were labeled Tdtom+ 
(Fig. 2d-f). Importantly, TAM injection labeled macrophages, but not monocytes in fetal liver 
(Supplementary Fig. 2a), and failed to label F4/80hiCD11blo macrophages in the arterial wall 
(Fig. 2d). Therefore, Tdtom+ macrophages likely derive from early YS EMPs independent of a 
monocyte intermediate. Normalization of arterial macrophage labeling to labeling of microglia 
(% Tdtom+ macrophages in the aorta / % Tdtom+ microglia), which are entirely of YS origin5,27, 
indicated that～60% of arterial macrophages at birth arise separate from fetal liver hematopoiesis 
(Fig. 2f). 
 
To address the possibility that fetal monocytes also contribute to the generation of arterial 
macrophages, we analyzed aortae in Flt3crex RosamT/mG reporter mice. Definitive hematopoietic 
  
stem and progenitor cells (HSPC) transiently augment FLT3 during differentiation to all 
hematopoietic lineages44. The approach, therefore, allowed us to identify HSPC-dependent GFP+ 
macrophages (FLT3-Cre+) and HSPC-independent GFP− macrophages (FLT3-Cre−). At birth, 
approximately 10 ± 1% and 28 ± 3% of F4/80hiCD11blo and F4/80intCD11bhi arterial 
macrophages, respectively, were GFP+ and derived entirely from fetal monocytes (Fig. 2g). Fetal 
monocytes are generated through both FLT-3-dependent and FLT-3-independent pathways10. 
The contribution of fetal liver hematopoiesis to development of the arterial macrophage pool, 
therefore, is likely underestimated. The data indicate that arterial macrophages are established 
through differentiation of early as well as late YS-derived EMPs.  
 
In adult mice, E8.5-labeled YS progenitors contributed to the macrophage pool in the aorta to a 
greater extent than the liver, lung and peritoneum (Fig. 2f,h). Moreover, the appearance of 
TdTomato MHCII+ arterial macrophages in adulthood (Fig. 2i) indicated that MHCII− cells gave 
rise to MHCII+ macrophages sometime after birth, because arterial macrophages in newborn 
mice were MHCII− (Fig. 2c). The persistence of YS-derived macrophages in the adult aorta was 
independently verified using Csf1rMeriCreMer x RosamTmG mice administered TAM at E8.5. These 
mice express the tamoxifen-inducible MerCreMer fusion protein under control of the 
macrophage specific mouse Csf1r promoter. YS-derived macrophages appear as GFP+ (Fig. 2j). 
The decline in YS labeling of arterial macrophages from ～60% at birth to ～20% in adulthood 
(Fig. 2e,f) could result from replacement of embryonic arterial macrophages by circulating 
monocytes9,28. To address this possibility, pregnant CX3CR1CreER mice were injected with TAM 
at E18.5. The approach labeled most arterial macrophages (and microglia) in CX3CR1creER 
R26Tomato mice at birth, but few blood monocytes (Fig. 2k,l). TdTomato labeling in arterial 
macrophages, but not microglia, decreased during the first 2 weeks of life (Fig. 2k,l), suggesting 
significant turnover and replacement of arterial macrophages with unlabeled circulating 
monocytes. Consistent with these observations, monocyte influx associated with increased 
perinatal expression in the aorta of the chemokine CCL2 and the cellular adhesion molecules 
VCAM-1, E-selectin and ICAM-1 (Fig. 2m, Supplementary Fig. 2b). We investigated the 
postnatal contribution of definitive hematopoiesis to the adult arterial macrophage pool further 
using Flt3crex RosamT/mG reporter mice. Flt3crex RosamT/mG Ly6Chi blood monocytes were GFP+ 
and derived entirely from HSPC precursors (Fig. 2n). In agreement with our previous 
  
observations, arterial macrophages in mice comprised both GFP+ and GFP− subsets, confirming 
the dual YS and HSPC origin of these cells (Fig. 2n,o). These observations suggest successive 
waves of arterial macrophage colonization, initially by an embryonic wave derived from early 
YS EMP and fetal liver monocytes9-11,24 followed by a brief influx of bone marrow-derived 
monocytes immediately after birth. 
 
CX3CL1-CX3CR1 interactions determine survival of arterial macrophages. 
Described differences in tissue-specific macrophage requirements for the growth factors 
macrophage-colony stimulating factor (M-CSF) and granulocyte macrophage-colony stimulating 
factor (GM-CSF)29,30 led us to assess arterial macrophages in Csf1−/− and Csf2−/− mice. We found 
significantly fewer arterial macrophages in the arteries of Csf1−/−, but not Csf2−/− mice compared 
to wild-type mice (Supplementary Figure 3a,b), consistent with other studies demonstrating 
profound macrophage deficiencies in M-CSF-deficient mice29. 
 
While many tissue macrophages lose expression of CX3CR1 as they mature13, adult mice retain 
its expression on a large proportion of arterial macrophages (Fig. 3a-c and Supplementary Fig. 
3c). Therefore, we investigated whether CX3CR1 contributed directly to the maintenance of 
arterial macrophages. CX3CR1−/− mice had fewer arterial macrophages than wild-type controls as 
assessed by confocal microscopy (Fig. 3d) and flow cytometry (Fig. 3e). Neutralizing antibodies 
directed against the CX3CR1 ligand CX3CL1 also decreased arterial macrophage numbers in 
wild type mice (Fig. 3f). Arterial macrophage proliferation was unchanged in CX3CR1-deficient 
mice compared to wild-type control mice (Fig. 3g), but the percentage of Fas+ macrophages 
(Fig. 3h) and the number of TUNEL+CD68+ cells (Fig. 3i) was increased in the vessel adventitia, 
suggesting that CX3CR1-CX3CL1 controls the survival of arterial macrophages. We next used 
CX3CL1cherry mice45, which have been modified to replace exon 1 of CX3CL1 with mCherry, to 
investigate the cellular source of CX3CL1. Confocal microscopy analysis of the arterial 
adventitia in CX3CL1cherry mice showed close proximity of CX3CL1 (Cherry)+ cells and CD68+ 
resident macrophages (Fig. 3j). Flow cytometry and immunofluorescence staining revealed 2 
main populations of CX3CL1+ cells in the aorta of CX3CL1cherry mice, namely CD31+ endothelial 
cells and PDGFRα+ mesenchymal cells (Fig. 3k,l). Therefore, arterial macrophage maintenance 
depends partially on a local CX3CR1-CX3CL1 axis. 
  
 
Arterial macrophages are maintained independent of monocytes in adulthood. 
To examine the mechanism of arterial macrophage renewal in adult mice, we examined the 
presence of arterial macrophages in mice deficient for the chemokine receptor CCR2, which 
have reduced numbers of circulating Ly6Chi monocytes35. The arteries of wild-type and Ccr2−/− 
mice contained comparable numbers of arterial macrophages (Fig. 4a), suggesting that 
macrophage turnover at steady-state occurs largely independent of circulating monocytes. To 
assess the rate of macrophage replacement in the arterial tissue, 8-week old C57BL/6J and UBC-
GFP mice, which express GFP under control of the human ubiquitin C promoter in all tissues, 
were joined by parabiosis for 8 months. While Ly6Chi and Ly6Clo monocyte chimerism in the 
blood at equilibrium was high (~32% and ~41%, respectively; Fig. 4b), as expected, macrophage 
chimerism in the aorta of parabiotic mice was low (~6%), suggesting that monocyte contribution 
to the arterial macrophage pool was limited. Macrophage chimerism was similarly low in the 
heart, lung and liver of parabiotic mice (Fig. 4b and12). As we have shown36, macrophage 
chimerism in the aorta alone in parabiotic mice underestimates the overall contribution of 
circulating monocytes to the arterial macrophage pool because Ly6Chi monocyte chimerism in 
the blood, even at equilibrium, is only ~32% (Fig. 4b). Assuming that individual GFP+ and 
C57BL/6J monocytes can infiltrate the arterial wall equally, for every C57BL/6J, partner-derived 
monocyte that entered the aorta of UBC-GFP mice, we also detected two endogenous (GFP+) 
infiltrating monocyte-derived macrophages. Hence, the total contribution of circulating 
monocytes (UBC-GFP and C57BL/6J) to macrophage accumulation was at most ~17% (Fig. 4c). 
Local expansion, which accounts for the remaining ~83% of F4/80hiCD11b+ macrophages, 
dominated arterial macrophage renewal during steady-state conditions (Fig. 4c). When we 
parabiotically linked Ccr2−/− and UBC-GFP (Ccr2+/+) mice for 5 weeks, monocyte chimerism 
(GFP+ cells) in the blood (CD115hi) and aortae (F4/80intCD11b+Ly6G−) of CCR2−/− partners was 
~82% and ~73%, respectively (Fig. 4d). Despite high chimerism of partner-derived wild-type 
monocytes in Ccr2−/− mice, chimerism of partner-derived F4/80hiCD11b+ arterial macrophages in 
Ccr2−/− mice remained low (~9%; Fig. 4d). We also independently assessed the monocyte 
contribution to the arterial macrophage pool by pulse labeling adult CX3CR1creER R26Tomato mice. 
Tamoxifen treatment induced CX3CR1-TdTomato expression in ~19% of blood Ly6Chi monocytes 
and ~59% of arterial macrophages (Fig. 4e). TdTomato expression remained high (~50%) among 
  
arterial macrophages at 9 and 11 months post labeling (Fig. 4e), but was absent in blood 
monocytes (Supplementary Fig. 4a and37), suggesting that maintenance of arterial macrophages 
depends little on blood monocytes. 
 
Persistence of pulse-labeled CX3CR1+ macrophages could also result from slow cell turnover. 
Therefore, arterial macrophage turnover was assessed in B6;129S4-Gt(ROSA)26Sortm1(rtTA*M2)Jae 
Col1a1tm7(tetO-HIST1H2BJ/GFP)Jae/J (H2B-GFP) mice, in which doxycycline treatment induces the 
expression of H2B-GFP ubiquitously38. Cellular expression of H2B-GFP was induced in adult 
mice by doxycycline treatment for 4 weeks and the loss of GFP fluorescence per cell, which is 
indicative of cell division, was monitored during a 2 month chase period. As expected, H2B-GFP 
expression in blood monocytes and arterial macrophages exceeded background by orders of 
magnitude following 4 weeks of doxycycline (Fig. 4f and Supplementary Fig. 4b). Consistent 
with observations that myeloid precursors turnover rapidly38, expression of H2B-GFP in blood 
Ly6Chi monocytes declined below the limit of detection after 2 months (Supplementary Fig. 
4b). H2B-GFP expression was also completely lost in some arterial macrophages (~25%) or the 
mean fluorescence intensity (MFI) of the GFP signal was dramatically reduced in others (Fig. 
4f), indicating significant turnover of arterial macrophages within 2 months. To estimate further 
the turnover and loss rate of arterial macrophages, we generated a mathematical model using a 3-
state absorbing continuous time Markov chain (CTMC). The approach assumed 2 transient states 
of GFP+ macrophages with different rates of GFP loss, and 1 absorbing state representing cells 
that have lost GFP expression (i.e. GFP– macrophages) (see Methods). Fitting the mathematical 
model to the observed dilution of the H2B-GFP signal in arterial macrophages suggested a 
turnover rate of ~84% every 12 months for these cells (Fig. 4g). Independently, 5-
bromodeoxyuridine (BrdU) injections into wild-type mice every other day for 9 days labeled 
25% of aortic macrophages (Fig. 4h and Supplementary Fig. 4c). Hence, arterial macrophage 
turnover is dynamic. 
  
Arterial macrophages self renew following exposure to bacteria. 
To address how arterial macrophages are replenished during inflammation we assessed 
macrophage repopulation in irradiated CD45.2+ mice transplanted with whole bone marrow from 
CD45.1+ mice. Recipient mice displayed near complete donor chimerism among blood 
  
leukocytes 6 months following transplantation (Fig. 5a). Brain microglia excepted39,40, donor 
chimerism of resident macrophages in the liver, heart, lung and aorta exceeded 70% (Fig. 5a), 
consistent with previous reports that lethal radiation impairs the local repopulation capacity of 
tissue-resident macrophages41.  
 
To assess macrophage turnover following infection, mice were either exposed to the Gram-
negative bacterial cell wall component, lipopolysaccharide (LPS) or subjected to surgical 
puncture of the cecum. The number of F4/80hiCD11b+CD115+Lyve-1+ resident arterial 
macrophages contracted immediately following LPS or cecal puncture (Fig. 5b and 
Supplementary Fig. 5a)42. Depletion of resident macrophages associated with accumulation of 
neutrophils (Supplementary Fig. 5b), Ly6Chi monocytes (Fig. 5b) and a distinct macrophage 
population identified as F4/80hiCD11b++CD115−Lyve-1− (Fig. 5b,c and Supplementary Fig. 
5c).  By one week, resident CD115+Lyve-1+ macrophage numbers rebounded to levels observed 
during steady state conditions (Fig. 5b,c,e), while neutrophils, monocytes and CD115−Lyve-1− 
macrophages were nearly absent (Fig. 5b,c and Supplementary Fig. 5b). Arterial macrophage 
numbers rebounded in LPS-exposed Ccr2−/− mice as well (Fig. 5b), indicating that local 
expansion rather than monocyte recruitment was the dominant mechanism of recovery. In 
agreement with this observation, LPS exposure increased the number of aortic macrophages in 
either S, G2, or M phases of the cell cycle compared to wild-type mice (Fig. 5f). In addition, we 
exposed parabiotic mice either to LPS or subjected them to cecal puncture. Partner chimerism 
was low among arterial resident CD115+Lyve-1+ macrophages, yet chimerism of newly 
infiltrating CD115−Lyve-1− macrophages was high, suggesting that monocytes were the 
immediate precursors of these cells (Fig. 5c,d). Intravenous transfer of Ly6Chi monocytes into 
LPS-treated mice showed that Ly6Chi monocytes gave rise to CD115−Lyve-1− macrophages, but 
not CD115+Lyve-1+ macrophages in the aorta (Fig. 5g). Moreover, CD115−Lyve-1− arterial 
macrophages displayed an increased in vivo capacity to phagocytose bacteria compared to 
CD115+Lyve-1+ arterial macrophages (Fig. 5h), indicating that functional differences exist 
between the two subsets of macrophages. 
 
To determine if YS-derived arterial macrophages respond differently than bone marrow-derived 
arterial macrophages, adult E8.5-labeled CX3CR1creER R26Tomato mice were either exposed to LPS 
  
or subjected to cecal puncture and assessed for the proportion of E8.5-labeled vs. unlabeled 
arterial macrophages during the macrophage recovery phase to determine the preferential 
expansion of one population over another. Neither LPS administration nor polymicrobial sepsis 
affected the percentage of F4/80hiCD11b+ macrophages that were Td tomato positive (Fig. 5i), 
suggesting equal self-renewal capabilities of the 2 subsets of arterial macrophages during 
infection. Microarray analysis of aortic macrophages during homeostasis and after recovery from 
sepsis revealed bacterial exposure had little effect on the transcriptional program of self-
renewing macrophages (Fig. 5j, Supplementary Fig. 5d). Of 10391 genes analyzed, only 12 
were differentially expressed, 10 increased and 2 decreased, in arterial macrophages from mice 
subjected to cecal puncture compared to steady-state control mice. In addition, in vitro, arterial 
macrophages could phagocytose bacteria before and after sepsis to the same extent 
(Supplementary Fig. 5e).  Therefore, arterial macrophages return to functional homeostasis 
rapidly after infection. 
 
Discussion 
Here, we identified the molecular signature of arterial macrophages, their developmental 
pathways and key mechanisms that ensure their homeostasis. Arterial macrophages, we showed, 
are distinct among tissue resident macrophages. Multiple fate mapping approaches demonstrated 
that arterial macrophages originate embryonically from CX3CR1+ precursors and postnatally 
from circulating monocytes immediately after birth. In adulthood, arterial macrophages were 
maintained by CX3CR1-CX3CL1 interactions and local proliferation rather than recruitment of 
circulating monocytes. Self-renewal also restored arterial macrophages to functional homeostasis 
after severe depletion induced by polymicrobial sepsis.  
 
The microarray database generated by the Immunological Genome Consortium provides a 
valuable resource for comparing gene-expression profiles of macrophages from different 
organs14. Consistent with evidence demonstrating diversity among macrophage populations, our 
gene expression and protein analyses revealed distinct patterns for arterial macrophages relative 
to other tissue macrophages. The data identified GO enrichment of transcripts with annotated 
functions that equip arterial macrophages for specialized local functions, supporting the concept 
  
that meaningful assessment of macrophage function requires careful consideration of the tissue 
context in which they reside. 
 
Tissue macrophages arise from 2 distinct developmental programs; early YS-derived erythro-
myeloid progenitors (EMPs) that give rise to macrophages without monocyte intermediates, and 
fetal monocytes that derive from late c-Myb+ EMPs generated in the YS10,11. These pathways 
contribute variously to macrophage development in several tissues including the brain, skin, 
heart, liver and lung5,8,13,23,24,43. Consistent with these findings, F4/80hiCD11blo arterial 
macrophages and F4/80loCD11bhi fetal monocytes were readily identified in aortae of embryonic 
(E16.5) mice. CX3CR1-, Csf1r-, and Flt3-driven fate mapping approaches indicated that arterial 
macrophages were derived from early YS EMPs as well as fetal monocytes. Our data also 
indicated that arterial macrophage colonization associates with a period bone marrow-derived 
monocyte recruitment shortly after birth. Development of the arterial macrophage pool, 
therefore, is unique. The maintenance of intestinal macrophages also depends on circulating 
monocytes, but renewal is constant and continues throughout adult life28. In arteries, the period 
of postnatal monocyte influx was brief, corresponding with transient expression of chemokines 
and cell adhesion molecules implicated in monocyte recruitment. While adult arteries contained 
sizeable populations of both YS and bone marrow-derived macrophages, the relative contribution 
of the 2 subsets of macrophages to vessel homeostasis remains unknown. 
 
In many tissues, resident macrophages lose expression of CX3CR1 during development13. In 
addition to retaining macrophage expression of the chemokine receptor in adulthood, CX3CL1 
blockade and examination of CX3CR1−/− mice indicated that CX3CR1-CX3CL1 interactions 
determine the survival of arterial macrophages, possibly through Fas-Fas ligand interactions. 
CX3CR1-CX3CL1 similarly promotes survival of macrophages in the brain31, kidney32, solid 
tumors34 and circulating Ly6Clo blood monocytes33. Visualization of the arterial macrophage 
niche using CX3CL1cherry reporter mice further showed that CD31+ endothelial cells and 
PDGFRα+ mesenchymal cells produced CX3CL1 locally in the artery. The relative contribution 
of these CX3CL1 producers to macrophage survival, however, is not known. The data also 
suggested the dependence of macrophage survival in the arterial wall on signaling pathways 
other than CX3CR1, because not all arterial macrophages express the receptor, and CX3CR1−/− 
  
mice still contain a moderate population of aortic macrophages. M-CSF deficiency similarly 
associated with fewer arterial macrophages, although it remains to be determined if M-CSF 
regulates macrophage differentiation, survival, and/or proliferation. 
 
Mathematical modeling of loss of arterial macrophages in H2B-GFP mice predicted near 
complete replacement of the macrophage population within ~1 year. Arterial macrophage 
turnover, therefore, is dynamic. Analysis of parabionts, CCR2−/− mice and pulse-labeled adult 
CX3CR1creER R26Tomato mice indicated that local proliferation rather than monocyte recruitment 
drives arterial macrophage renewal in the steady state and during polymicrobial sepsis. This 
result contrasts with a report on macrophage maintenance in the heart, where bone marrow-
derived cells progressively replaced macrophages with age9. The data further showed that the 
arterial macrophage response to bacteria is many-sided. Infection led first to the recruitment of 
Ly6Chi monocytes and their differentiation into CD115−Lyve-1− macrophages that functioned to 
phagocytose bacteria. This was followed by the self-renewal and re-establishment of functional 
homeostasis of CD115+Lyve-1+ resident macrophages. The diversity of origins (successive 
contributions of YS, fetal liver and conventional hematopoiesis) of arterial macrophages 
highlights the importance of tissue-specific extrinsic factors, including CX3CR1-CX3CL1 
interactions, in maintaining their abundance. Of note, macrophage proliferation also amplifies 
arterial pathology, as we have previously observed in atherosclerosis36. Therefore, future design 
of therapeutic strategies that target arterial macrophages will require not only elucidation of the 
mechanisms that maintain them, but their activities in specific disease contexts.
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Online Methods 
Animals 
C57BL/6J (WT), B6.Cg-Tg(Itgax-Venus)1Mnz/J (CD11c-eYFP), B6.129P2(Cg)-
Cx3cr1tm2.1(cre/ERT)Litt/WganJ (CX3CR1CreER), 129S-Zbtb46tm1Kmm/J (Zbtb46GFP/+), B6.129P2(C)-
Cx3cr1tm2.1(cre/ERT2)Jung/J (CX3CR1CreER), B6.129P-Cx3cr1tm1Litt/J (CX3CR1gfp/+), B6.Cg-
Tg(Cx3cl1/mCherry)1Jung/J (CX3CL1cherry), B6.129S4-Ccr2tm1Ifc/J (CCR2−/−), B6;C3Fe a/a-
Csf1op/J (M-CSF−/−), B6;129S4-Gt(ROSA)26Sortm1(rtTA*M2)Jae Col1a1tm7(tetO-HIST1H2BJ/GFP)Jae/J 
(H2B-GFP), and B6.SJL-PtprcaPep3b/BoyJ (CD45.1), C57BL/6-Tg(UBC-GFP)30Scha/J mice 
were all purchased from Jackson Laboratories. B6.129-Cx3cr1tm1Zm (Cx3cr1−/−), 
C57BL/6NTac were purchased from Taconic. Flt3-Cre and Csfr1-Mer-iCre-Mer mice, which 
were crossed with Rosa mTmG C57BL6/J reporter mice, were kindly provided by Dr. Slava 
Epelman and Dr. Gwendalyn Randolph. Dr. Filip Swirski provided Csf2rb−/− (GM-CSFR−/−) 
mice. Studies were carried out using both male and female mice. All animal protocols were 
approved by the Animal Resource Centre, University Health Network (AUP# 2902), Toronto, 
ON.  
 
Animal models and in vivo interventions 
Fate-mapping approaches: CX3CR1CreER females were bred with R26tdTomato males to generate 
heterozygous CX3CR1CreER; R26tdTomato offspring. To label yolk sac-derived cells, tamoxifen was 
administered to pregnant females at E8.5 via intra-peritoneal (i.p.) injection at a concentration of 
75µg/g body weight. At E19.5-20.5, pregnant mothers were c-sectioned and pups fostered. The 
same pup fostering protocol was applied to E18.5 labeling. 
Tamoxifen preparation: 100mg of tamoxifen-free base (Sigma-Aldrich T5648) was added to 0.5 
mL 95% ethanol. 9.5mL corn oil was then added to the mixture and vortexed until dissolved. 
LPS administration/Induction of polymicrobial sepsis: LPS (50µg) (O55:B5 Sigma-Aldrich) was 
administered by intra-peritoneal injection. A rodent model of sepsis was induced by opening the 
peritoneal cavity during isoflurane anesthesia. The distal end of the cecum was then perforated 
using a 23 G needle, and a small drop of feces was extruded through the puncture. The cecum 
was relocated into the peritoneal cavity, and the peritoneum was closed. Animals were 
resuscitated by subcutaneous injection of 1 mL of saline. 
H2B-GFP induction: H2B-GFP expression was induced in B6; 129S4-Gt(ROSA) 
  
26Sortm1(rtTA*M2) Jae Col1a1tm7 (tetO-HIST1H2BJ/GFP) Jae/J mice by adding doxycycline hyclate (Sigma-
Aldrich) (dissolved at a concentration of 2mg/mL in autoclaved water and 1%w/vol of sucrose) 
to the water supply for 4 weeks. 
BrdU incorporation studies: 1 mg BrdU (FITC BrdU Flow Kit; BD Pharmingen) was injected 
i.p. every other day for 9 days. 
Monocyte depletion: Mice were injected i.v. on 5 consecutive days with 200μl of either PBS 
(control)- or clodronate-loaded liposomes (5 mg/ml) (clodronateliposomes.com).  
Parabiosis: Briefly, after shaving the corresponding lateral aspects of each mouse, matching skin 
incisions were made from behind the ear to the tail of each mouse, and the subcutaneous fascia 
was bluntly dissected to create about 1⁄2 cm of free skin. The olecranon and knee joints were 
attached by a mono-nylon 5.0 (Ethicon, Albuquerque, NM), and the dorsal and ventral skins 
were approximated by continuous suture. Percent chimerism was defined as %GFP+ / (%GFP+ + 
%GFP−) in GFP− mice, and as %GFP− / (%GFP− + % GFP+) in GFP+ mice. 
Bone Marrow Transplantation: Naïve wild type mice (CD45.2+) were lethally irradiated (10 Gy). 
4-7 hours after irradiation, animals were reconstituted with CD45.1+ total bone marrow cells 
from B6.SJL-PtprcaPep3b/BoyJ mice. A total of 3×106 cells were injected intravenously. 
Animals were allowed to recover for a minimum of 10 weeks. 
Phagocytosis: Aortic macrophages were harvested from C57/B6J wild-type animals before and 
7-day following induction of sepsis by cecal puncture and incubated with pHrodo™ E. coli 
BioParticles® (Life Technologies) according to the manufacturer’s protocol. Phagocytic activity 
was determined by flow cytometry. For in vivo phagocytosis assays, C57/B6 adult mice were 
injected with LPS (50 ug) and 8 hours later injected intravenously with of 200 uL of pHrodo™ 
E. coli BioParticles® at a concentration of 2 mg/mL. Aortic macrophages were harvested 4 hours 
post injection of E. coli particles (12 hours after LPS). Phagocytic activity was determined by 
flow cytometry. 
CX3CL1 Blockade: C57/B6 adult mice were implanted with osmotic pumps (Alzet 200 microlitre 
micro-osmotic pumps) containing either CX3CL1 neutralizing antibody (R&D MAB571) or 
ratIgG2a isotype control antibody (R&D MAB006) for 10 days. 
Ly6Chigh monocyte adoptive transfer: Bone marrow cells were collected from the spines, hips, 
femurs, tibias and fibulas of adult C57BL/6-Tg (UBC-GFP)30Scha/J mice. Magnetic-activated cell 
sorting was used to sort on CD115+ cells. Ly6Chigh monocytes were subsequently flow-sorted on 
  
CD115+Ly6Chigh. Immediately after LPS injection, 3 million Ly6ChighCD115+GFP+ monocytes 
were injected intravenously. Aortae were collected from transplant recipients at time points after 
LPS exposure as indicated in figures. 
 
Cells. 
Isolation and ex vivo methods: Peripheral blood for flow cytometric analysis was collected by 
cardiac puncture using a 50 mM EDTA solution as anticoagulant. Erythrocytes were lysed using 
RBC Lysis Buffer (BioLegend). The total white blood cell count was determined by preparing a 
1:20 dilution of (undiluted) peripheral blood obtained from the orbital sinus using heparin-coated 
capillary tubes in RBC Lysis Buffer (BioLegend). After organ harvest, single-cell suspensions 
were obtained as follows: for bone marrow, the femur of one leg was crushed with mortar and 
pestle and homogenized through a 40-μm-nylon mesh. Spleens were homogenized through a 40-
μm-nylon mesh, after which RBC lysis was performed using RBC Lysis Buffer (BioLegend). 
For aortic tissue, the aorta was perfused with10 ml PBS before digestion. The entire aorta (from 
the aortic sinus to the iliac bifurcation) was cut in small pieces and subjected to enzymatic 
digestion with 450 U ml−1 collagenase I, 125 U ml−1 collagenase XI, 60 U ml−1 DNase I and 60 
U ml−1 hyaluronidase (Sigma-Aldrich) for 10 to 40 minutes (depending on age) at 37 °C while 
shaking. Liver, lung, heart, femoral and carotid arteries were also processed in the same manner 
and digested for 30 minutes. Single-cell suspensions of digested tissues were obtained by 
homogenizing digested tissue though 40-μm-nylon mesh. Single-cell suspensions of brain tissue 
were obtained by direct homogenization through a 40-μm-nylon mesh. 
 
Confocal Microscopy.  
En face immune-staining was performed as described previously (1, 2). Mice were perfused with 
PBS followed by 2% paraformaldehyde (PFA), and the ascending aorta was dissected. Aortas 
were permeabilized with 0.2% Triton X-100 and 0.1M Glycine for 10 minutes at room 
temperature, and endogenous peroxidase activity was by quenched by incubating with 3% H2O2 
was for 45 minutes. Biotin-conjugated anti-mouse CD68 (Abd Serotec) and was incubated 
overnight at 4oC. Samples were then incubated with Streptavidin HRP for 30 minutes, followed 
by FITC-conjugated Tyramide for 10 minutes (Perkin Elmer). To visualize CX3CL1, rabbit anti-
mCherry (1:200; Novus Biologicals, NBP-2-25157) was incubated overnight followed by 
  
staining with goat anti-rabbit Alexa Flour 568 (1:400; ThermoFisher Scientific, A-11046) 
secondary antibodies for 2 hours at room temperature on select samples. Nuclei 
were counterstained with Hoechst 33342 (Molecular Probes). For TUNEL staining, aortae were 
incubated with TUNEL reaction mixture (TMR red In situ Cell Death Detection Kit, Roche 
Applied Science) for 1h at 37oC. The arch was opened and mounted on glass slides with the 
intima facing the cover slip. En face images were obtained using a confocal microscope 
equipped with 40X and 60X oil objectives (FluoView-1000; Olympus). For FLT3-cre x Rosa-
mTmG and Csfr1-Mer-iCre-Mer x Rosa-mTmG lineage tagging studies, aortas were fixed in 4% 
PFA and 30% sucrose, then blocked with 0.2% BSA, 0.1% Triton X-100, and 5% donkey serum 
in PBS and immune-stained with rat anti-mouse CD68 (Bio-Rad MCA1957). Samples were then 
stained with Cy5-conjugated secondary antibody (Jackson ImmunoResearch) raised in donkey 
against ratIgG and imaged using a Leica SPE confocal microscope.  
For immunofluorescence on aortic cross-sections, tissues were fixed in 4% PFA, rinsed 
with PBS, then cryoprotected with 20% sucrose in PBS and frozen in OCT. 5 μm transverse 
cryosections were dried at room temperature for 10 minutes, fixed for 15 minutes in 2% PFA, 
rinsed 3 times in 1x PBS, then blocked for 1 hour in 2% normal goat serum in PBS.  Sections 
were then incubated with either rat anti-CD31 (1:200; Novus Biologicals, NB600-1475) or rat 
anti-CD140a (1:200; BD Biosciences, 558774) and rabbit anti-mCherry overnight. Sections were 
then rinsed 3 times in 1x PBS, then incubated goat anti-rat Alexa Flour 647 (1:400; 
ThermoFisher Scientific, A-21247) and goat anti-rabbit Alexa Flour 568 secondary antibodies 
for 2 hours at room temperature, protected from light.  Nuclei were counterstained with 10 μg/ml 
Hoechst 33258 in ddH2O for 10 minutes before slides were mounted with 50:50 glycerol:PBS 
and stored at -20C° until imaging.  Images were captured on an Zeiss Observer V spinning disk 
confocal microscope.   
 
RNA Microarray. 
Aortic macrophages (CD11bhighF4/80highCD45+MerTK+CD64+) were isolated from C57/B6 wild-
type male mice aged 6-8 weeks before and 7 days after induction of sepsis by cecal puncture. 18-
20 aortas were pooled per sample. Sorting was conducted on the MoFlo Astrios BRVY. Arterial 
macrophage purity was >99% (Supplementary Fig. 5). RNA was extracted using the PicoPure 
RNA Isolation Kit (Life Technologies). The total concentration and quality of RNA was 
  
determined using an Agilent 2100 Bioanalyzer (Agilent Technologies) according to the 
manufacturer’s instructions. RNA transcripts were amplified using the Nugen ovation Pico WTA 
V2 kit. 3ng of total RNA was amplified according the manufacturer’s protocol. The 
amplification of RNA included amplification at the 3' end as well random amplification 
throughout the transcript using Ribo-SPIA technology. 5ug of cDNA was used to generate ST-
cDNA using the WT-Ovation Exon Module and 5ug of ST-cDNA was fragmented and labeled 
with Encore Biotin Module. RNA was hybridized on the Affymetrix Mouse Gene 1.0 ST array. 
Arrays were hybridized at 45oC for 16-18 hours, washed with Affymetrix fluidic station p450 
and scanned with Affymetrix 7G scanner. Affymetrix gene expression console was for QC and 
to generate QC reports. 
 
Probe set expression levels were calculated using the multi-array procedure (RMA), which is 
available within the oligo Bioconductor package for the R statistical software project where raw 
intensity values were background corrected and normalized (3). Probe sets with no gene 
assignments and/or raw intensities < 120 were filtered out. In cases where multiple probe sets 
mapped onto a single gene, the probe set with the highest intensity was selected for further 
analysis. Principal component analysis was performed to compare naive arterial macrophage 
microarray data to published data sets from Immgen (4) for lung CD103+ DC (538231, 538232, 
538233), SI CD103+DC (854251, 854252, 854253), MLN CD4+DC (538242,538243, 538244), 
MLN CD8+DC (538252, 538253, 538254), lung alveolar MF (538282, 538283, 538284), SI 
CD11b+ MF (854262, 854263, 854264), microglia (854326, 854327, 854328), and RP MF 
(605853, 605854, 605855) using the prcomp command in R. RMA-adjusted values were then 
compared using a student`s t-test with significance set p < 0.05. 
 
qRT-PCR  
RNA was extracted from whole aorta using a TRIzol® (Life Technologies) according to 
manufacturer protocol.  RNA concentration was obtained using a Nanodrop ND100 
spectrophotometer.  cDNA was synthesized using qScript cDNA SuperMix (Quanta 
BioSciences) according to manufacturer protocol.  Transcripts were then detected using specific 
primers (see Supplementary Table 5) using SYBR Green Master (Roche) detected on a 
  
LightCycler 480 (Roche).  Hprt was used as the housekeeping gene; values were compared using 
the 2-Δ ΔCt method.  Samples were run in triplicate and averaged. 
 
Mathematical modeling. 
MΦ turnover was predicted in mice with ubiquitous, doxycycline-inducible expression of an 
H2B-GFP fusion protein using a Continuous Time Markov Chain (CTMC). The system was 
modeled as a 3-state absorbing CTMC, two transient states representing the two GFP+ 
populations of macrophages having different rates of GFP loss and one absorbing state 
representing the cells that lost the GFP signal (i.e. became GFP negative) (Supplementary 
Table 2). This system generates a matrix of differential equations and each equation represents 
the transition probability rate equation of one cell moving between any two states. This matrix is 
the product of two other matrices, the probability matrix P, which contains the Probability 
density function for the transitions between any two states, and the matrix of rates Q, which 
contains the values of the probability rates. Assuming Initial conditions of [0.7 0.3 0]; the form 
of the Markov Chain shows a representation of unconditional probabilities of reaching each state, 
and has the following form: 
 (1) 
 
From (1), a total of three simultaneous differential equations can be derived through matrix 
multiplication. Solving the three differential equations simultaneously gives the following three 
equations: 
   (2) 
 (3) 
 (4) 
Where k, c, A are arbitrary constants of integrations. 
 
Next, the integration constants were determined using the Initial Conditions stated previously. 
For the purpose of the modeling and because of the properties of the Markov chains, only the k 
  
and c were determined as A can be easily calculated using the normality property of the Markov 
chains. Determination of the values of constants and substituting with them gives the equations 
for the probability (i.e. proportion) of each cell population, in this case two macrophage 
populations, being GFP+ at any given time point: 
 
 (5) 
 (6) 
Adding equations (5) and (6) gives the general equation for the percent GFP+ cells at any time 
point: 
 
 (7) 
Where X=3/10 and Y=7/10.  
X and Y represent the values that change with the initial conditions of the system. All other 
parameters are independent of the initial conditions. This equation was then plugged into the 
non-linear regression fitting code of Mathematica. The fitting was done on the data shown in 
Supplementary Table 2. Each row was treated as a separate experiment and was fitted separately 
to increase the accuracy of the model. The average of each of the coefficients from all four 
fittings was taken and plugged into the original equation. In the case of the proportions being 
3/10 and 7/10, the simplified equation becomes the following; 
 
 (8) 
 
Where λ1= 0.15187/month, λ2=0.043141/month, and D= 0.10915/month.  
 
All values were generated to a precision level up to the 13th decimal place, but for simplicity, we 
are only showing up to the 4th decimal place. The fitting was successful for the MFI data as well 
with changed coefficients, therefore fulfilling the conditions placed on the model previously 
(Data not shown). 
The resulting fit in equation (8) (Hence forth referred to as Average fit) was plotted on 
Matlab; an extra constant term was added to the model to correct for any changes in the starting 
  
point from 100. This was done for normalization purposes to match the normalization condition 
in the DOX on procedure and the changes made by the term were on the order of 0.1-1, hence it 
was not significant to the values of the model. The values were imported into the curve-fitting 
tool Matlab. The tool compares the function to the values generated and generates an R2-value 
and then plots the data points to validate the model and calculates the validation Sum of the 
Square of Errors (SSE) and the Root Mean Square Error (RMSE) (which is the same as the 
standard deviation), both of which should be minimized (Supplementary Tables 2, 3). The curve 
fitting tool was run on the four fittings along with their respective datasets (Supplementary Table 
3) and the Average fit function was run four times, each time using a different data set (one of the 
four experiments) (Supplementary table 3). The R2-values for all runs was 1.0, which confirms 
that the model is working and the SSE and RMSE values for each run are shown in 
Supplementary Table 3 and Supplementary Table 4. The RMSE on average was 5.75, which is 
acceptable as a difference of +/- 5 is not significant on the range of the dependent variable in this 
case, which is from 0-100. The Average fit was then plotted with the corresponding error bars for 
each calculated data point as well as the data point in the same plot for visual confirmation that 
the points lie within the prediction limits of the model. To confirm that our model predictions 
and strength are independent of the initial conditions used in the calculations; equation (7) was 
imported into Matlab with the average values of the coefficients substituted and the values 
marked in yellow were changed in accordance with 0.1 steps. The functions produced from all 
steps were plotted on the same plot along with the Average fit. All the plots were identical and 
there was a small difference between them and the Average fit which is owing to the difference 
in the significance and number of decimal places generated during the simplification process. 
The difference is not significant, however (Data not shown). 
 
Flow cytometry. 
Antibodies to the following were used for flow cytometric analyses are provided in 
Supplementary Table 5. Data was acquired on an LSRII flow cytometer (BD Biosciences) and 
analyzed with FlowJo v8.8.6 (Tree Star, Inc.). Aorta, heart, liver, lung, and brain tissue were 
treated with FcBlock (BD Biosciences) for 15 minutes prior to incubation with antibody cocktail 
for an additional 30 minutes. Samples were fixed prior to flow analysis (BD Cytofix). Cell-cycle 
analysis was carried out using FxCycle violet stain (Invitrogen) on 95% ethanol fixed samples. 
  
 
Statistics. 
Results are expressed as either mean ± SEM or mean ± SD. The statistical tests used included 
unpaired Student's t test using Welch's correction for unequal variances and one-way analysis of 
variance followed by Tukey's or Newman-Keuls multiple comparison test. P ≤ 0.05 was 
considered to denote significance. 
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Figure 1. Phenotype and gene expression profiling of arterial macrophages. (a) 
Identification of aortic macrophages. Contour plots demonstrate gating scheme for 
F4/80+CD11b+aortic macrophages, F4/80loCD11c+MHCII+ dendritic cells (DC) and 
Ly6Chi/loF4/80loCD64+ monocytes in 6-8 week old C57BL6/J mice (mean ± SEM; n = 15). (b) 
Principal component analysis of whole genome microarray data from isolated arterial 
macrophages, compared to macrophages and DC populations collected by the Immunological 
Genome Project (GSE15907). For arterial macrophages, expression data are pooled from 3 
independent experiments. (c) Heat map of mRNA transcripts increased in arterial macrophages 
by fivefold or more relative to their expression in microglia, splenic red pulp macrophages, and 
alveolar macrophages. (d) Heat map of mRNA transcripts decreased in arterial macrophages by 
fivefold or more relative to their expression in the remaining 3 macrophage populations. (e) Flow 
cytometry analysis of cell surface markers expressed by arterial macrophages, Kupffer cells, 
alveolar macrophages, and microglia (filled histograms). Open histograms = isotype controls. (f) 
Zbtb46-GFP expression in macrophages (filled histograms) and DC (open histograms) from 
aorta, liver, lung, and brain of Zbtb46gfp/+ mice. One experiment of two is shown. Dashed lines = 
wild type macrophages (GFP−), dotted lines = wild type DC (GFP−). (g) CD11c-eYPF 
expression in arterial macrophages and DC from CD11ceYFP/+ mice. Data show one of 3 animals 
examined (h) Flow cytometry analysis of arterial macrophages in adventitial and intima/media 
compartments (mean ± SEM; adventitia n = 27, intima/media n = 22). Data show individual 
animals pooled from 4 independent experiments. * P < 0.0001 (unpaired t-test). (i) Enumeration 
of arterial macrophages from (h) (mean ± SEM; adventitia n = 27, intima/media n = 22). Data 
show individual animals pooled from 4 independent experiments. * P < 0.0001 (unpaired 
Student’s t-test). (j) CD68 staining of adventitia and intima/media from ascending, descending, 
thoracic, and abdominal aortic segments (mean ± SD; n = 3). * total aorta P < 0.0001, ascending 
arch P = 0.0006, descending arch P < 0.0001, thoracic P < 0.0001, abdominal P < 0.0003 
(unpaired t-test). Data show individual mice pooled from one experiment. 
 
Figure 2. Arterial macrophages have embryonic and postnatal origins. (a) Phenotypic 
analysis of arterial macrophages before and after birth. Dot plots show representative F4/80 and 
CD11b staining at multiple ages. (b) Macrophage accumulation over time expressed as a 
percentage of total CD45+ leukocytes (n = 31). Data show individual mice analyzed at multiple 
  
time points. P = 0.0051 (linear regression analysis). (c) Major histocompatibility (MHC) II 
expression on arterial macrophages over time (n = 34). Data show individual mice analyzed at 
multiple time points. P < 0.0001 (linear regression analysis). (d) E8.5-induced CX3CR1-TdTomato 
expression in F4/80highCD11blow and F4/80intCD11bhigh arterial macrophages at E16.5 (mean ± 
SD; n = 6). Data show a representative histogram from one of 6 mice analyzed. (e) 
Representative histograms illustrating E8.5-induced CX3CR1-TdTomato expression in arterial 
macrophages at DOB and 10 weeks of age. (f) Time course of E8.5-induced CX3CR1-TdTomato 
expression in arterial macrophages and Kupffer cells normalized to CX3CR1-TdTomato expression 
in brain microglia (mean ± SD; E16.5 n = 6, DOB n = 7, PND3 n = 1, PND13 n = 3, PND50 n = 
3, PND70 n = 2). (g) Identification of FLT3-Cre+ (GFP+) macrophages (aorta) in newborn 
(DOB) Flt3crex RosamT/mG reporter mice (mean ± SEM; n = 9). Data show representative 
histograms from one of 9 mice examined. (h) CX3CR1-TdTomato expression in macrophages 
isolated from aorta, liver (Kupffer cells), lung (alveolar macrophages), and peritoneum 
normalized to CX3CR1-TdTomato expression in brain microglia. Macrophages isolated from mice 
at PND50 (mean ± SD; n = 3 mice per tissue). (i) CX3CR1-TdTomato expression in MHCII− and 
MHCII+ arterial macrophages from mice at PND50 (mean ± SD; n = 3). (j) Immunofluorescence 
(IF) showing GFP+ YS-derived arterial macrophages in aortic adventitia of adult Csf1rMeriCreMer x 
RosamTmG mice administered TAM at E8.5. Shown is a representative image from one of 3 
animals examined. (k) Representative histograms illustrating CX3CR1-TdTomato expression in 
arterial macrophages of neonatal (PND2) and adult mice administered TAM at E18.5. (l) E18.5-
induced CX3CR1-TdTomato expression in arterial macrophages, circulating Ly6Chigh monocytes, 
and microglia over time (mean ± SD; DOB n=1, PND2 n = 3, PND3 n = 2, PND14 n = 4, 
PND35 n = 2, PND 43 n = 2). (m) MCP-1 and VCAM-1 expression detected by RT-PCR and 
conducted on aortic tissue taken from mice at indicated time points (mean ± SD; n = 4 mice per 
time point except t = 1 where n = 3).* P < 0.05 (unpaired t-test). (n) Identification of FLT3-Cre+ 
(GFP+) monocytes (blood) and macrophages (aorta) in adult Flt3crex RosamT/mG reporter mice 
(mean ± SD; n = 3). Data show representative histograms from one of 3 mice examined. (o) 
Representative IF imaging from animals in (o) showing co-localization of FLT3-Cre 
recombination (GFP) and CD68 (Texas Red) in aortic adventitia of adult Flt3crex RosamT/mG 
reporter mice. 
 
  
Figure 3. CX3CL1-CX3CR1 interactions determine survival of arterial macrophages. (a) IF 
showing GFP staining in aortic adventitia of CX3CR1gfp/+ mice. Shown is a representative image 
from one of 3 animals examined. (b) Dot plots show GFP staining is mainly limited to CD45+ 
arterial macrophages in aortae of CX3CR1gfp/+ mice. (c) Representative histogram shows ~70% of 
F4/80+CD11b+ arterial macrophages express CX3CR1 (mean ± SD; n = 3). (d) CD68 staining of 
aortic adventitia in wild type and CX3CR1−/− mice. Data show individual mice pooled from one 
experiment (mean ± SEM; n = 7).* P < 0.0001 (unpaired t-test). (e) Enumeration of arterial 
macrophages in wild type and CX3CR1−/− mice by flow cytometry. Data show individual mice 
pooled from 3 independent experiments (mean ± SEM; wild type n = 15, CX3CR1−/− mice n = 
14).* P = 0.045 (unpaired t-test). (f) Arterial macrophage abundance in mice following antibody-
mediated neutralization of CX3CL1. Data show individual mice pooled from two independent 
experiments (mean ± SEM, isotype n = 11, anti-CX3CL1 n =12). * P = 0.042 (unpaired t-test). 
(g) Percentage of aortic macrophages from wild type and CX3CR1−/− mice in S and G2/M phases 
of the cell cycle (mean ± SD; wild type n = 4, CX3CR1−/− n = 5). Data show individual mice 
pooled from one experiment. P = 0.09 (unpaired t-test). (h) Percentage of aortic macrophages 
expressing Fas in wild type and CX3CR1−/− mice (mean ± SEM, n = 7). Data show individual 
mice pooled from one experiment. * P = 0.0083 (unpaired t-test). (i) Enumeration of 
TUNEL+CD68+ cells in aortic adventitia of wild type and CX3CR1−/− mice (mean ± SEM, n = 7). 
* P < 0.0001 (unpaired t-test). (j) IF showing association of adventitial aortic macrophages 
(CD68+) with CX3CL1+ cells in CX3CL1cherry mice. Shown is a representative image from one of 
several mice examined. (k) Representative dot plots showing arterial expression of CX3CL1 in 
CD45−PDGFRα+ and CD45−CD31+ cells. 3 animals were analyzed (mean ± SD). (l) IF showing 
localization of CX3CL1 and either CD31+ or PDGFRα+ cells. Shown are representative images 
from one of 3 animals examined. 
 
Figure 4. Arterial macrophages are maintained independent of monocytes in adulthood. (a) 
Enumeration of aortic macrophages in wild type (WT) and CCR2−/− mice (mean ± SEM; wild 
type n = 6, CCR2−/− n = 5). Data show individual mice pooled from two independent 
experiments. P = 0.79 (unpaired t-test). (b) Wild type and GFP mice were joined in parabiosis 
for 8 months. Data show Ly-6Chigh and Ly-6Clow monocyte chimerism in the blood, and 
macrophage chimerism in the aorta, heart, lung, and liver. For monocytes, data show individual 
  
mice pooled from 6 pairs of parabionts. For macrophages, data show individual mice pooled 
from 2 pairs of parabionts (mean ± SEM; monocytes n = 12, MΦ n = 4). (c) GFP and CCR2−/− 
mice were joined in parabiosis for 6 weeks. Data show monocyte chimerism in the blood, and 
macrophage chimerism in the aorta, heart, lung, and liver. Data show individual animals pooled 
from 1 pair of parabionts (mean ± SD; n = 2). (d) Relative contribution of local renewal and 
monocyte recruitment to macrophage accumulation over 8 months. (e) Representative 
histograms showing CX3CR1-TdTomato expression in arterial macrophages 1 week and 9-11 
months following TAM exposure (mean ± SD; 1 week n = 3, 9 months n = 2, 11 months n = 1). 
(f) Adult TetOP-H2B-GFP mice were administered doxycycline for 4 weeks to induce H2B-GFP 
expression and then loss of fluorescence in aortic macrophages (indicative of cell division) was 
monitored during a 2 month chase period (mean ± SD; n = 4). (g) Mathematical model predicts 
rate of loss of GFP+ macrophages over time (see Methods). (h) 5-bromodeoxyuridine (BrdU) 
incorporation by aortic macrophages (mean ± SD; n = 5). Data show individual animals pooled 
from one experiment. 
 
Figure 5. Arterial macrophages self renew following exposure to bacteria. (a) Bone marrow 
chimeras were generated by reconstituting lethally irradiated CD45.2+ mice with CD45.1+ bone 
marrow cells. Data show chimerism in blood CD45+ leukocytes and macrophages in the heart, 
lung (alveolar), aorta, liver (Kupffer cells), and brain (microglia) (mean ± SD; n = 3). (b) 
Enumeration of Ly6Chigh monocytes, CD115+ macrophages (resident), CD115− macrophages 
(bone marrow monocyte-derived), and resident macrophages in CCR2−/− mice following 
exposure to LPS. Data were collected at multiple time points (mean ± SD; day 0 n = 8, 4h n = 3, 
12h n = 3, 24h n = 3, 72h n = 4, 120h n = 4, 336h n = 3, 648h n = 3). (c) Dot plots from CD45.1+ 
parabiont demonstrating chimerism in CD115+Lyve-1+ and CD115−Lyve-1− macrophages. Data 
show a representative CD45.1 partner. (d) Wild type and GFP mice were joined in parabiosis for 
6 weeks. Mice were either injected with lipopolysaccharide (LPS) or subjected to cecal puncture. 
Data show chimerism in blood monocytes and aortic macrophages 7 days following bacterial 
exposure (mean ± SD; n = 4). Data show individual mice pooled from 2 pairs of parabionts. (e) 
IF showing CD68 staining in adventitia and intima of aorta 7 days following exposure to LPS. 
Shown is a representative image from one of 4 animals examined. (f) Number of aortic 
macrophages in S and G2/M phases of the cell cycle 5 days after LPS administration. Data show 
  
individual mice pooled from one experiment (mean ± SD, n = 6). * P = 0.0026 (unpaired t-test). 
(g) Mice were exposed to LPS and injected with flow-sorted Ly6Chigh bone marrow monocytes. 
At the indicated time points following LPS exposure, the percentage of CD115+ (resident) and 
CD115− (bone marrow monocyte-derived) macrophages that were GFP+ is reported. Data show 
that monocytes give rise to CD115−, but not CD115+ macrophages (mean ± SD; day 0 n = 8, 4h n 
= 3, 12h n = 3, 24h n = 3, 72h n = 4, 240h n = 4, 648h n = 3). (h) CD115− and CD115+ 
macrophages were assessed for their in vivo capacity to phagocytose pHrodo™ E. coli 
BioParticles® 12h following exposure to LPS. Data demonstrate that bacteria are taken up by 
CD115− macrophages (mean ± SEM; n = 5). Dot plots show representative images from one 
animal of 5. Two independent experiments were performed. (i) E8.5-induced CX3CR1-TdTomato 
expression in arterial macrophages 7 days after either LPS administration or induction of sepsis 
by cecal puncture. Data show individual mice pooled from two independent experiments (mean 
± SEM, control n = 5, LPS n = 5, sepsis n = 4). (j) Volcano plot demonstrating gene expression 
changes in aortic macrophages before and after sepsis. Of 10391 genes analyzed, only 10 genes 
were up-regulated (red) and 2 genes down-regulated (blue) in macrophages from mice subjected 
to cecal puncture (n = 3 independently collected samples per experimental group). 





